国际皮肤性病学杂志    2004 30 (2): 108-110   ISSN: 2096-5540  CN: 32-1880/R   表皮调节素 李翠华, 彭振辉 西安交通大学第二医院皮肤科, 710004 收稿日期 2003-04-17  修回日期 null  网络版发布日期 null 参考文献  [1] Toyoda H, Komurasaki T, Uchida D, et al. Epiregulin. A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem, 1995, 270(13):7495-7500. [2] Toyoda H, Komurasaki T, Uchida D, et al. Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J, 1997, 326(Pt 1):69-75. [3] Torring N, Jorgensen PE, Sorensen BS, et al. Increased expression of heparin binding EGF(HB-EGF), amphiregulin, TGF alpha and epiregulin in androgen-independent prostate cancer cell lines. Anticancer Res, 2000, 20(1A):91-95. [4] Zhu Z, Kleeff J, Friess H, et al. Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem Biophys Res Commun, 2000, 273(3):1019-1024. [5] Baba I, Shirasawa S, Iwamoto R, et al. Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signaling pathway in human colon cancer cells. Cancer Res, 2000, 60(24):6886-6889. [6] Thogersen VB, Sorensen BS, Poulsen SS, et al. A subclass of HER1ligands are prognostic markers for survival in bladder cancer patients.Cancer Res, 2001,61(16):6227-6233. [7] Das SK, Das N, Wang J, et al. Expression of betacellulin and epiregulin genes in the mouse uterus temporally by the blastocyst solely at the site of its apposition is coincident with the "window" of implantation. Dev Biol, 1997, 190(2):178-190. [8] Yamanaka Y, Hayashi K, Komurasaki T, et al. EGF family liganddependent phenotypic modulation of smooth muscle cells through EGF receptor. Biochem Biophys Res Commun, 2001,281(2):373-377. [9] Komurasaki T, Toyoda H, Uchida D, et al. Mechanism of growth promoting activity of epiregulin in primary cultures of rat hepatocytes.Growth Factors, 2002, 20(2):61-69. [10] Mishra R, Leahy P, Simonson MS. Gene expression profiling reveals role for EGF-family ligands in mesangial cell proliferation. Am J Physiol Renal Physiol, 2002, 283(5):F11S1-1159. [11] Sasaki E, Arakawa T, Fujiwara Y, et al. Epiregulin stimulates proliferation of rabbit gastric cells in primary cuhure through autophosphorylation of the epidermal growth factor receptor. Eur J Pharmacol,1997, 338(3):253-258. [12] Sekiguchi T, Mizutani T, Yamada K, et al. Transcriptional regulation of the epiregulin gene in the rat ovary. Endocrinology, 2002, 143(12):4718-4729. [13] Miettinen PJ, Berger JE, Meneses J, et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor.Nature, 1995, 376(6538):337-341. [14] Stoll SW, Kansra S, Peshick S, et al. Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes, Neoplasia, 2001,3(4):339-350. [15] Shelly M, Pinkas-Kramarski B, Guarino BC, et al. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem, 1998, 273(17):10496-10505. [16] Komurasaki T, Toyoda H, Uchida D, et al. Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3and ErbB-4. Oncogene, 1997, 15(23):2841-2848. [17] Shirakata Y, Komurasaki T, Toyoda H, et al. Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem, 2000, 275(8):5748-5753. [18] Draper BK, Komurasaki T, Davidsoh MK, et al. Topical epiregnlin enhances repair of murine excisional wounds. Wound Repair Regen,2003, 11(3):188-197. [19] Draper BK, Komurasaki T, Davidson MK, et al. Epiregnlin is more potent than EGF or TGFalpha in promoting in vitro wound closure due to enhanced ERK/MAPK activation. J Cell Biochem. 2003, 89(6):1126-1137. [20] Cook PW, Piepkorn M, Clegg CH, et al. Transgenic expression of the human amphiregnlin gene induces a psoriasis-like phenotype. J Clin Invest, 1997, 100(9):2286-2294. 通讯作者: